A detailed history of Green Alpha Advisors, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 297,637 shares of DNA stock, worth $98,220. This represents 0.26% of its overall portfolio holdings.

Number of Shares
297,637
Previous 201,795 47.49%
Holding current value
$98,220
Previous $341,000 1.17%
% of portfolio
0.26%
Previous 0.25%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

BUY
$1.06 - $1.67 $101,592 - $160,056
95,842 Added 47.49%
297,637 $345,000
Q4 2023

Jan 04, 2024

SELL
$1.26 - $1.79 $104,385 - $148,294
-82,846 Reduced 29.11%
201,795 $341,000
Q3 2023

Oct 10, 2023

BUY
$1.61 - $2.54 $194,232 - $306,428
120,641 Added 73.56%
284,641 $515,000
Q2 2023

Jul 06, 2023

BUY
$1.14 - $1.95 $84,360 - $144,300
74,000 Added 82.22%
164,000 $305,000
Q1 2023

Apr 06, 2023

BUY
$1.2 - $2.19 $108,000 - $197,100
90,000 New
90,000 $119,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $425M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Green Alpha Advisors, LLC Portfolio

Follow Green Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.